查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1970815

全球自动化乳房超音波系统市场规模、份额、趋势和成长分析报告（2026-2034年）

Global Automated Breast Ultrasound Systems Market Size, Share, Trends & Growth Analysis Report 2026-2034
出版日期: | 出版商: Value Market Research | 英文 110 Pages | 商品交期: 最快1-2个工作天内

价格
简介目录

预计到 2034 年，自动乳房超音波系统市场规模将从 2025 年的 29.7 亿美元成长至 96.9 亿美元，2026 年至 2034 年的复合年增长率为 14.06%。

随着对早期癌症检测和先进诊断成像的需求不断增长，全球自动化乳房超音波（ABUS）市场预计将持续扩张。 ABUS作为乳房X光摄影的补充手段，正日益受到重视，尤其适用于乳房组织緻密的女性，因为传统影像方法可能不足以满足她们的需求。高解析度3D成像、自动化扫描通讯协定和基于人工智慧的解读工具的整合，提高了诊断的可靠性，并降低了操作者差异。

由于其高效性、缩短的检查时间和高患者处理能力，医疗机构正优先考虑自动乳房超音波（ABUS）解决方案。超音波换能器技术、影像重建演算法和使用者友善介面的不断改进，正推动医院、诊断中心和乳房护理诊所的临床应用不断扩展。自动化、云端资料储存和远端医疗平台的结合，进一步扩大了已开发市场和新兴市场获得先进诊断影像服务的机会。

展望未来，基于深度学习的检测演算法的进步、与磁振造影（MRI）和数位乳房X光摄影的多重模式融合以及即时4D成像技术有望将自动乳房超音波（ABUS）的诊断准确率提升到一个新的水平。公共筛检计画的扩展、预防医学意识提升以及个人化医疗的推广等趋势也有望促进市场成长。结合技术创新和全球卫生政策，ABUS将继续成为降低全球乳癌死亡率的核心工具。

目录

第一章：引言

第二章执行摘要

第三章 市场变数、趋势与框架

  • 市场谱系展望
  • 渗透率和成长前景分析
  • 价值链分析
  • 法律规范
    • 标准与合规性
    • 监管影响分析
  • 市场动态
    • 市场驱动因素
    • 市场限制因素
    • 市场机会
    • 市场挑战
  • 波特五力分析
  • PESTLE分析

第四章：全球自动化乳房超音波系统市场：依产品划分

  • 市场分析、洞察与预测
  • 自动乳房容积扫描仪
  • 自动乳房超音波系统（ABUS）

第五章：全球自动化乳房超音波系统市场：依最终用途划分

  • 市场分析、洞察与预测
  • 医院
  • 诊断影像检查实验室
  • 其他的

第六章 全球自动化乳房超音波系统市场：依地区划分

  • 区域分析
  • 北美市场分析、洞察与预测
    • 我们
    • 加拿大
    • 墨西哥
  • 欧洲市场分析、洞察与预测
    • 英国
    • 法国
    • 德国
    • 义大利
    • 俄罗斯
    • 其他欧洲国家
  • 亚太市场分析、洞察与预测
    • 印度
    • 日本
    • 韩国
    • 澳洲
    • 东南亚
    • 其他亚太国家
  • 拉丁美洲市场分析、洞察与预测
    • 巴西
    • 阿根廷
    • 秘鲁
    • 智利
    • 其他拉丁美洲国家
  • 中东和非洲市场分析、洞察与预测
    • 沙乌地阿拉伯
    • UAE
    • 以色列
    • 南非
    • 其他中东和非洲国家

第七章 竞争情势

  • 最新趋势
  • 公司分类
  • 供应链和销售管道合作伙伴（根据现有资讯）
  • 市场占有率和市场定位分析（基于现有资讯）
  • 供应商情况（基于现有资讯）
  • 策略规划

第八章：公司简介

  • 主要公司的市占率分析
  • 公司简介
    • GE HealthCare
    • Koninklijke Philips NV
    • Siemens Healthcare Private Limited
    • Canon Medical Systems Corporation
    • Telemed Medical Systems Srl
    • Hologic Inc
    • SuperSonic Imagine
    • Lunit Inc
    • Delphinus Medical Technologies Inc
简介目录
Product Code: VMR112111348

The Automated Breast Ultrasound Systems Market size is expected to reach USD 9.69 Billion in 2034 from USD 2.97 Billion (2025) growing at a CAGR of 14.06% during 2026-2034.

The global automated breast ultrasound systems (ABUS) market is positioned for expansion as demand for early cancer detection and advanced diagnostic imaging grows. ABUS is increasingly being deployed as a complementary modality to mammography, particularly for women with dense breast tissue where conventional imaging may lack accuracy. Integration of high-resolution 3D imaging, automated scanning protocols, and AI-based interpretation tools is enhancing diagnostic confidence and reducing inter-operator variability.

Healthcare providers are prioritizing ABUS solutions for their efficiency, reduced examination time, and capability to handle high patient throughput. Continuous improvements in ultrasound transducer technology, image reconstruction algorithms, and user-friendly interfaces are expanding clinical adoption across hospitals, diagnostic centers, and breast care clinics. The combination of automation with cloud-based data storage and telemedicine platforms is further broadening access to advanced imaging in both developed and emerging markets.

Looking forward, advances in deep learning-based detection algorithms, multi-modality integration with MRI and digital mammography, and real-time 4D imaging will elevate ABUS to the next level of diagnostic precision. The market is expected to benefit from public screening programs, rising awareness of preventive healthcare, and the ongoing push for personalized medicine. With technological innovation and global health initiatives converging, ABUS will remain a pivotal tool in reducing breast cancer mortality rates worldwide.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Product

  • Automated Breast Volume Scanner
  • Automated Breast Ultrasound (ABUS)

By End Use

  • Hospital
  • Diagnostics Imaging Laboratories
  • Others

COMPANIES PROFILED

  • GE HealthCare, Koninklijke Philips NV, Siemens Healthcare Private Limited, Canon Medical Systems Corporation, Telemed Medical Systems srl, Hologic Inc, SuperSonic Imagine, Lunit Inc, Delphinus Medical Technologies Inc
  • We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definition
  • 1.3. Information Procurement
    • 1.3.1 Information Analysis
    • 1.3.2 Market Formulation & Data Visualization
    • 1.3.3 Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

  • 2.1. Market Snapshot
  • 2.2. Segmental Outlook
  • 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

  • 3.1. Market Lineage Outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Value Chain Analysis
  • 3.4. Regulatory Framework
    • 3.4.1 Standards & Compliance
    • 3.4.2 Regulatory Impact Analysis
  • 3.5. Market Dynamics
    • 3.5.1 Market Drivers
    • 3.5.2 Market Restraints
    • 3.5.3 Market Opportunities
    • 3.5.4 Market Challenges
  • 3.6. Porter's Five Forces Analysis
  • 3.7. PESTLE Analysis

Chapter 4. GLOBAL AUTOMATED BREAST ULTRASOUND SYSTEMS MARKET: BY PRODUCT 2022-2034 (USD MN)

  • 4.1. Market Analysis, Insights and Forecast Product
  • 4.2. Automated Breast Volume Scanner Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.3. Automated Breast Ultrasound (ABUS) Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL AUTOMATED BREAST ULTRASOUND SYSTEMS MARKET: BY END USE 2022-2034 (USD MN)

  • 5.1. Market Analysis, Insights and Forecast End Use
  • 5.2. Hospital Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.3. Diagnostics Imaging Laboratories Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.4. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL AUTOMATED BREAST ULTRASOUND SYSTEMS MARKET: BY REGION 2022-2034(USD MN)

  • 6.1. Regional Outlook
  • 6.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 6.2.1 By Product
    • 6.2.2 By End Use
    • 6.2.3 United States
    • 6.2.4 Canada
    • 6.2.5 Mexico
  • 6.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 6.3.1 By Product
    • 6.3.2 By End Use
    • 6.3.3 United Kingdom
    • 6.3.4 France
    • 6.3.5 Germany
    • 6.3.6 Italy
    • 6.3.7 Russia
    • 6.3.8 Rest Of Europe
  • 6.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 6.4.1 By Product
    • 6.4.2 By End Use
    • 6.4.3 India
    • 6.4.4 Japan
    • 6.4.5 South Korea
    • 6.4.6 Australia
    • 6.4.7 South East Asia
    • 6.4.8 Rest Of Asia Pacific
  • 6.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 6.5.1 By Product
    • 6.5.2 By End Use
    • 6.5.3 Brazil
    • 6.5.4 Argentina
    • 6.5.5 Peru
    • 6.5.6 Chile
    • 6.5.7 South East Asia
    • 6.5.8 Rest of Latin America
  • 6.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 6.6.1 By Product
    • 6.6.2 By End Use
    • 6.6.3 Saudi Arabia
    • 6.6.4 UAE
    • 6.6.5 Israel
    • 6.6.6 South Africa
    • 6.6.7 Rest of the Middle East And Africa

Chapter 7. COMPETITIVE LANDSCAPE

  • 7.1. Recent Developments
  • 7.2. Company Categorization
  • 7.3. Supply Chain & Channel Partners (based on availability)
  • 7.4. Market Share & Positioning Analysis (based on availability)
  • 7.5. Vendor Landscape (based on availability)
  • 7.6. Strategy Mapping

Chapter 8. COMPANY PROFILES OF GLOBAL AUTOMATED BREAST ULTRASOUND SYSTEMS INDUSTRY

  • 8.1. Top Companies Market Share Analysis
  • 8.2. Company Profiles
    • 8.2.1 GE HealthCare
    • 8.2.2 Koninklijke Philips N.V
    • 8.2.3 Siemens Healthcare Private Limited
    • 8.2.4 Canon Medical Systems Corporation
    • 8.2.5 Telemed Medical Systems Srl
    • 8.2.6 Hologic Inc
    • 8.2.7 SuperSonic Imagine
    • 8.2.8 Lunit Inc
    • 8.2.9 Delphinus Medical Technologies Inc